HLA-B*0702 & B2M & HPV16 E7 (KPTLKEYVL)

HLA-B*0702 & B2M & HPV16 E7 (KPTLKEYVL) Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    His Tag & Avi Tag (1)Flag Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (2)

HLA-B*0702 & B2M & HPV16 E7 (KPTLKEYVL) Background

Human papillomavirus (HPV) is A kind of papillomavirus belonging to the milk polypoid virus family. It is a spherical D virus, which can cause the proliferation of squamous epithelium of human skin mucosa. HPV(human papillomavirus) for common warts, genital warts (condyloma acuminatum), and other symptoms. There are many types of human papillomavirus (HPV), with HPV 16 and 18 being high-risk types known to significantly increase the risk of cervical, vaginal and vulvar cancers in women and men. This human HLA-B*0702 HPV (KPTLKEYVL) complex protein is a complex of HLA-B*0702 of the MHC Class I, B2M, and KPTLKEYVL peptide of the HPV.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
COM-701COM-701Phase 2 ClinicalCompugen LtdOvarian Neoplasms; Head and Neck Neoplasms; Solid tumours; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Lung Neoplasms
Details
SIM-0348SIM-0348Phase 1 ClinicalSimcere Pharmaceutical Group LtdSolid tumours; Neoplasms
Details
GSK-4381562SRF-813; GSK-4381562Phase 1 ClinicalSurface Oncology IncNeoplasms
Details
NM1FNM1F; TGI-2Phase 1 ClinicalHefei TG ImmunoPharma Co LtdSolid tumours; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Melanoma
Details
SHR-2002SHR-2002Phase 1 ClinicalNeoplasms
Details
JS-009JS009; TAB009; JS-009Phase 1 ClinicalShanghai Junshi Biosciences Co LtdSolid tumours; Neoplasms
Details
PM-1009PM1009Phase 1 ClinicalBiotheus IncSolid tumours; Neoplasms; Lung Neoplasms
Details
  • Product List
  • Clinical Drug Information